Program Description/Abstract This application is the competitive renewal of my first R01 grant entitled 'The MKP-1/p38 axis: coordinating innate and adaptive immunity'. T cell-mediated immune dysregulation is an important cause of many human inflammatory disorders. For instance, the TH17 subset of effector T cells is highly pathogenic in autoimmune diseases including multiple sclerosis (MS) and its murine model experimental autoimmune encephalomyelitis (EAE). Much emphasis has been placed on T cell-intrinsic molecular and transcriptional pathways in immune reactions, but how T cells interact with innate immunity and target tissues remains elusive. Indeed, the crosstalk between innate and adaptive immunity is a fundamental question in immunology, originally dubbed as 'immunologist's dirty little secret'by the late Dr. Charles Janeway. The identification of TLRs an other pattern-recognition receptors (PRRs) has revolutionized our understanding of immune priming, but it remains unclear how the diverse signals are integrated by intracellular signaling i innate and inflammatory cells to crosstalk with T cells. The central theme of the original grant was to test whether innate immune signals mediated by the MKP-1 and p38 pathway coordinate innate and adaptive immunity. The hypothesis was proven, and we have established p38? as one of the first major signaling pathways in dendritic cells (DCs) to integrate innate and inflammatory signals for programming TH17 differentiation. The potent and unique function of DC p38? signaling in modulating TH17 but not TH1 or TH2 responses presents a remarkable opportunity for mechanistic dissection and therapeutic intervention. Our preliminary results also revealed a role of p38? signaling in TH17 target cells (i.e. CNS-resident cells) in EAE, as well a in DC-mediated inflammatory responses. We hypothesize that the p38?/MKP-1 signaling axis acts in tissue-resident cells and DCs to mediate the crosstalk with T cells and regulate inflammatory responses. To this end, we propose three highly integrated aims, to determine how T cells especially TH17 cells function in EAE by impinging upon tissue-resident cells (Aim 1), to explore how T cell responses are shaped by DC signals (Aim 2), and to further extend this to the reciprocal interaction between T cells and DCs (Aim 3). Thus, the proposal centers upon the p38?/MKP-1 signaling in the non-T cell compartment and its interaction with T cells in biology and disease. Insights gained from this application may significantly impact our understanding of the interface between innate and adaptive immunity and manifest legitimate therapeutic opportunities.

Public Health Relevance

Statement T cell-mediated immune dysregulation is an important cause of many human inflammatory disorders. For instance, the TH17 subset of effector T cells is highly pathogenic in autoimmune diseases including multiple sclerosis (MS), an inflammatory demyelinating disease of CNS affecting approximately 400,000 Americans. Much emphasis has been placed on T cell-intrinsic molecular and transcriptional pathways in immune reactions, but how T cells interact with innate immune cells (e.g. dendritic cells) and target tissues remains elusive. Therefore, a better understanding of the immune signaling in these cells is essential for our efforts to prevent and treat multiple sclerosis and other diseases

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS064599-06A1
Application #
8825073
Study Section
Innate Immunity and Inflammation (III)
Program Officer
Utz, Ursula
Project Start
2008-07-01
Project End
2019-06-30
Budget Start
2014-09-30
Budget End
2015-06-30
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
City
Memphis
State
TN
Country
United States
Zip Code
38105
Zeng, Hu; Cohen, Sivan; Guy, Cliff et al. (2016) mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation. Immunity 45:540-54
Wei, Jun; Long, Lingyun; Yang, Kai et al. (2016) Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat Immunol 17:277-85
Shrestha, Sharad; Yang, Kai; Guy, Cliff et al. (2015) Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol 16:178-87
Zeng, Hu; Chi, Hongbo (2015) Metabolic control of regulatory T cell development and function. Trends Immunol 36:3-12
Huang, Gonghua; Wang, Yanyan; Vogel, Peter et al. (2015) Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosis. Sci Signal 8:ra24
Chapman, Nicole M; Chi, Hongbo (2014) mTOR signaling, Tregs and immune modulation. Immunotherapy 6:1295-311
Wei, Jun; Yang, Kai; Chi, Hongbo (2014) Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision. J Immunol 193:4297-301
Mahmud, Shawn A; Manlove, Luke S; Schmitz, Heather M et al. (2014) Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat Immunol 15:473-81
Karmaus, Peer W F; Chi, Hongbo (2014) Genetic dissection of dendritic cell homeostasis and function: lessons from cell type-specific gene ablation. Cell Mol Life Sci 71:1893-906
Yang, Kai; Chi, Hongbo (2014) Metabolic Control of Th17 Cell Generation and CNS Inflammation. J Neurol Neurophysiol Suppl 12:

Showing the most recent 10 out of 31 publications